Job Overview
Job description
- Location:
- Australia
- Work arrangement:
- On-site
Role Summary
Thank you for your interest in working for our Company. Recruiting the right talent is crucial to our goals. On April 1, 2024, 3M Healthcare underwent a corporate spin-off leading to the creation of a new company named Solventum . We are still in the process of updating our Careers Page and applicant documents, which currently have 3M branding. Please bear with us. In the interim, our Privacy Policy here: continues to apply to any personal information you submit, and the 3M-branded positions listed on our Careers Page are for Solventum positions. As it was with 3M, at Solventum all qualified applicants will receive consideration for employment without regard to their race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
We are seeking an experienced/qualified Health Information Manager to join the Solventum Health Information Systems (HIS) division. You will utilise your organisational and planning skills to be an integral member of this successful team as we expand our portfolio and expand into the development of computer assisted coding products. This role will only suit a self-motivated, tenacious and successful professional with a true passion for results.
This position involves
Working as part of a team in the development of HIS products for the Australian health industry
Both interstate and intrastate travel as required
Requirements
The successful person will have
Degree or equivalent in Health Information Management
- Significant and recent experience working with ICD-10-AM (including 12th Edition) and the AR-DRG Grouper
- Strong understanding of the processes associated with documentation in electronic medical record systems.
- Ability to design processes in line with software functionality.
- Strong communication skills
- Confidence in delivering group presentations
- Strong Microsoft 365 skills
- Certificate IV in Training and Assessment would be viewed favourably.
- Solventum is committed to maintaining the highest standards of integrity and professionalism in our recruitment process. Applicants must remain alert to fraudulent job postings and recruitment schemes that falsely claim to represent Solventum and seek to exploit job seekers.
- Please note that all email communications from Solventum regarding job opportunities with the company will be from an email with a domain of @solventum.com . Be wary of unsolicited emails or messages regarding Solventum job opportunities from emails with other email domains.
- Please note: your application may not be considered if you do not provide your education and work history, either by: 1) uploading a resume, or 2) entering the information into the application fields directly.
Solventum Global Terms of Use and Privacy Statement
- Carefully read these Terms of Use before using this website. Your access to and use of this website and application for a job at Solventum are conditioned on your acceptance and compliance with these terms.
- Please access the linked document by clicking here, select the country where you are applying for employment, and review. Before submitting your application you will be asked to confirm your agreement with the
- terms.
- Role:
- Clinical Support Specialist
- Job Type:
- Full Time
Company profile

Solventum
solventum.comSolventum Corporation is a US health care company that was spun off from the 3M group on 1 April 2024. It took over 3M's wound and oral care, health IT and biopharmaceutical filtration businesses. The business was registered in Delaware in January 2023 under the provisional name 3M Health Care Co., and the name Solventum, a coinage from the words solving and momentum, was announced in November 2023. 3M kept a share of the listed company after the separation, and in February 2025 Thermo Fisher Scientific took over Solventum's purification and filtration division.
- Company Size
- 10,000 - 50,000 employees
- Headquarters
- Saint Paul, Minnesota, United States
- Founded
- 2024
- Funding Stage
- Public